Download PDF
Int J Angiol
DOI: 10.1055/s-0044-1779663
Original Article

miR-2467-3p/ABLIM1 Axis Mediates the Formation and Progression of Deep Vein Thrombosis by Regulating Inflammation and Oxidative Stress

Yu Qiu
1   Department of Vascular and Endovascular Surgery, Second Affiliated Hospital of Naval Medical University, Shanghai, China
,
Meiying Yang
2   Department of Trauma Orthopedics, Zibo Central Hospital, Zibo, China
,
Xinting Che
3   Department of Vascular and Endovascular Surgery, School of Medicine, Xiamen University, Xiamen, China
,
Xinming Yu
4   Department of Vascular Surgery, Zibo Central Hospital, Zibo, China
,
Kangkang Zhi
1   Department of Vascular and Endovascular Surgery, Second Affiliated Hospital of Naval Medical University, Shanghai, China
› Author Affiliations Funding This study was funded by Shanghai 2020 “Science and Technology Innovation Action Plan” Biomedical Science and Technology Support Special Project (20S31902000) and the National Natural Science Foundation of China (81971710).
› Further Information
    Permissions and Reprints

Abstract

Deep vein thrombosis (DVT) is a common postoperative complication of orthopaedic surgery with a complex pathogenesis mechanism. The effect of the miR-2467-3p/acting-binding LIM protein 1 (ABLIM1) axis on thrombus formation and human vascular endothelial cells (HUVECs) progression was evaluated aiming to identify a novel potential biomarker of DVT. DVT rat models were established by inferior vena cava stenosis. The expression of the miR-2467-3p/ABLIM1 axis was analyzed by PCR. HUVECs were induced with oxidative low-density lipoprotein (ox-LDL). Cell growth and motility were assessed by cell counting kit 8 (CCK8) and Transwell assay. The inflammation and oxidative stress were estimated by proinflammatory cytokines and generation of MDA and reactive oxygen species (ROS). ABLIM1 was downregulated in DVT rats. Overexpressing ABLIM1 could suppress the formation of thrombosis and alleviate inflammation and oxidative stress. In HUVECs, ox-LDL induced significantly increased miR-2467-3p and decreased ABLIM1, and miR-2467-3p could negatively regulate ABLIM1. The knockdown of miR-2467-3p could alleviate the inhibited cell growth and motility by ox-LDL, and the inflammation and oxidative stress were also attenuated. While silencing could reverse the effect of miR-2467-3p on ox-LDL-induced HUVECs. The miR-2467-3p/ABLIM1 axis regulates the occurrence and development of DVT through modulating HUVECs inflammation and oxidative stress.

Keywords

microRNA - HUVECs injury - ceRNA - cell proliferation - cell migration

Authors' Contributions

Y.Q. and X.M.Y designed the research study. M.Y.Y and X.T.C performed the research. Y.Q., X.M.Y, and K.K.Z analyzed the data and wrote the manuscript. All authors contributed to editorial changes in the manuscript. All authors read and approved the final manuscript.


Ethical Approval

The study protocol was approved by The Ethics Committee of Zibo Central Hospital and followed the principles outlined in the Declaration of Helsinki.


Patient Consent

Iinformed consent has been obtained from the participants involved.




Publication History

Article published online:
21 February 2024

© 2024. International College of Angiology. This article is published by Thieme.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Spencer FA, Gore JM, Lessard D, Douketis JD, Emery C, Goldberg RJ. Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous Thromboembolism Study. Arch Intern Med 2008; 168 (04) 425-430
    CrossrefPubMedGoogle Scholar
  • 2 Di Nisio M, van Es N, Büller HR. Deep vein thrombosis and pulmonary embolism. Lancet 2016; 388 (10063): 3060-3073
    CrossrefPubMedGoogle Scholar
  • 3 Stubbs MJ, Mouyis M, Thomas M. Deep vein thrombosis. BMJ 2018; 360: k351
    CrossrefPubMedGoogle Scholar
  • 4 Bandeira FC, Pitta GB, Castro AA, Miranda Jr F. Postoperative incidence of deep vein thrombosis after major lower extremity amputation. Int Angiol 2008; 27 (06) 489-493
    PubMedGoogle Scholar
  • 5 Lin HY, Lin CY, Huang YC. et al. Deep vein thrombosis after major orthopedic surgery in Taiwan: a prospective cross-sectional study and literature review. J Formos Med Assoc 2022; 121 (08) 1541-1549
    CrossrefPubMedGoogle Scholar
  • 6 Saleh J, El-Othmani MM, Saleh KJ. Deep vein thrombosis and pulmonary embolism considerations in orthopedic surgery. Orthop Clin North Am 2017; 48 (02) 127-135
    CrossrefPubMedGoogle Scholar
  • 7 Yu X, Wu Y, Ning R. The deep vein thrombosis of lower limb after total hip arthroplasty: what should we care. BMC Musculoskelet Disord 2021; 22 (01) 547
    CrossrefPubMedGoogle Scholar
  • 8 Navarrete S, Solar C, Tapia R, Pereira J, Fuentes E, Palomo I. Pathophysiology of deep vein thrombosis. Clin Exp Med 2022; 23 (03) 645-654
    CrossrefPubMedGoogle Scholar
  • 9 Yang B, Zhang Z. Suppression of long intergenic non-protein coding RNA 1123 constrains lower extremity deep vein thrombosis via microRNA-125a-3p to target interleukin 1 receptor type 1. Bioengineered 2022; 13 (05) 13452-13461
    CrossrefPubMedGoogle Scholar
  • 10 Chen P, Liu Y, Lin X, Yu B, Chen B, Lin F. The underlying molecular basis and mechanisms of venous thrombosis in patients with osteomyelitis: a data-driven analysis. Genet Res 2022; 2022: 5672384
    CrossrefPubMedGoogle Scholar
  • 11 Liu D, Wang X, Liu Y, Li C, Zhang Z, Lv P. Actin-binding LIM 1 (ABLIM1) inhibits glioblastoma progression and serves as a novel prognostic biomarker. Dis Markers 2022; 2022: 9516808
    PubMedGoogle Scholar
  • 12 Dong X, Feng M, Yang H. et al. Rictor promotes cell migration and actin polymerization through regulating ABLIM1 phosphorylation in hepatocellular carcinoma. Int J Biol Sci 2020; 16 (15) 2835-2852
    CrossrefPubMedGoogle Scholar
  • 13 Chen X, Huang Y, Shi D. et al. LncRNA ZNF667-AS1 promotes ABLIM1 expression by adsorbing micro RNA-1290 to suppress nasopharyngeal carcinoma cell progression. OncoTargets Ther 2020; 13: 4397-4409
    CrossrefPubMedGoogle Scholar
  • 14 Narahara H, Sakai E, Yamaguchi Y. et al. Actin binding LIM 1 (abLIM1) negatively controls osteoclastogenesis by regulating cell migration and fusion. J Cell Physiol 2018; 234 (01) 486-499
    CrossrefPubMedGoogle Scholar
  • 15 Jin SH, Kim H, Gu DR. et al. Actin-binding LIM protein 1 regulates receptor activator of NF-κB ligand-mediated osteoclast differentiation and motility. BMB Rep 2018; 51 (07) 356-361
    CrossrefPubMedGoogle Scholar
  • 16 Duan Z, Wei S, Liu Y. Circ_0074027 contributes to non-small cell lung cancer progression through positively modulating RHOA via sequestering miR-2467-3p. J Bioenerg Biomembr 2021; 53 (02) 223-233
    CrossrefPubMedGoogle Scholar
  • 17 Gao SL, Fan Y, Liu XD, Liu W, Zhao M. circ_0089153 exacerbates breast cancer cells proliferation and metastasis via sponging miR-2467-3p/E2F6. Environ Toxicol 2022; 37 (06) 1458-1471
    CrossrefPubMedGoogle Scholar
  • 18 Liu F, Wen C. LINC01410 knockdown suppresses cervical cancer growth and invasion via targeting miR-2467-3p/VOPP1 axis. Cancer Manag Res 2020; 12: 855-861
    CrossrefPubMedGoogle Scholar
  • 19 Wang P, Pan Y, Yang C. et al. TNFα activation and TGFβ blockage act synergistically for smooth muscle cell calcification in patients with venous thrombosis via TGFβ/ERK pathway. J Cell Mol Med 2022; 26 (16) 4479-4491
    CrossrefPubMedGoogle Scholar
  • 20 Nguyen KP, McGilvray KC, Puttlitz CM, Mukhopadhyay S, Chabasse C, Sarkar R. Matrix metalloproteinase 9 (MMP-9) regulates vein wall biomechanics in murine thrombus resolution. PLoS ONE 2015; 10 (09) e0139145
    CrossrefPubMedGoogle Scholar
  • 21 Shi KN, Li PB, Su HX, Gao J, Li HH. MK-886 protects against cardiac ischaemia/reperfusion injury by activating proteasome-Keap1-NRF2 signalling. Redox Biol 2023; Jun; 62: 102706
    CrossrefPubMedGoogle Scholar
  • 22 Diaz JA, Hawley AE, Alvarado CM. et al. Thrombogenesis with continuous blood flow in the inferior vena cava. A novel mouse model. Thromb Haemost 2010; 104 (02) 366-375
    PubMedGoogle Scholar
  • 23 Brill A, Fuchs TA, Chauhan AK. et al. von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood 2011; 117 (04) 1400-1407
    CrossrefPubMedGoogle Scholar
  • 24 Hassanian SM, Avan A, Ardeshirylajimi A. Inorganic polyphosphate: a key modulator of inflammation. J Thromb Haemost 2017; 15 (02) 213-218
    CrossrefPubMedGoogle Scholar
  • 25 Borgel D, Bianchini E, Lasne D, Pascreau T, Saller F. Inflammation in deep vein thrombosis: a therapeutic target?. Hematology 2019; 24 (01) 742-750
    CrossrefPubMedGoogle Scholar
  • 26 Wang Q, Zennadi R. Oxidative stress and thrombosis during aging: the roles of oxidative stress in RBCs in venous thrombosis. Int J Mol Sci 2020; 21 (12) 4259
    CrossrefPubMedGoogle Scholar
  • 27 Wang KS, Liu X, Aragam N. et al. Polymorphisms in ABLIM1 are associated with personality traits and alcohol dependence. J Mol Neurosci 2012; 46 (02) 265-271
    CrossrefPubMedGoogle Scholar
  • 28 Ghafouri-Fard S, Khoshbakht T, Hussen BM, Taheri M, Samadian M. A review on the role of miR-1290 in cell proliferation, apoptosis and invasion. Front Mol Biosci 2021; 8: 763338
    CrossrefPubMedGoogle Scholar
  • 29 Cao J, Shen Y, Zhu L. et al. miR-129-3p controls cilia assembly by regulating CP110 and actin dynamics. Nat Cell Biol 2012; 14 (07) 697-706
    CrossrefPubMedGoogle Scholar
  • 30 Hassanlou M, Soltani BM, Mowla SJ. Expression and function of hsa-miR-6165 in human cell lines and during the NT2 cell neural differentiation process. J Mol Neurosci 2017; 63 (02) 254-266
    CrossrefPubMedGoogle Scholar
  • 31 Xu Y, Ouyang C, Lyu D. et al. Diabetic nephropathy execrates epithelial-to-mesenchymal transition (EMT) via miR-2467-3p/Twist1 pathway. Biomed Pharmacother 2020; 125: 109920
    CrossrefPubMedGoogle Scholar
  • 32 Bombeli T, Karsan A, Tait JF, Harlan JM. Apoptotic vascular endothelial cells become procoagulant. Blood 1997; 89 (07) 2429-2442
    CrossrefPubMedGoogle Scholar
  • 33 Gao C, Xie R, Li W. et al. Endothelial cell phagocytosis of senescent neutrophils decreases procoagulant activity. Thromb Haemost 2013; 109 (06) 1079-1090
    Article in Thieme ConnectPubMedGoogle Scholar
  • 34 Zifkos K, Dubois C, Schäfer K. Extracellular vesicles and thrombosis: update on the clinical and experimental evidence. Int J Mol Sci 2021; 22 (17) 9317
    CrossrefPubMedGoogle Scholar
  • 35 Xie HX, Wang YH, Zhang JH. et al. Design, synthesis and biological evaluation of marine phidianidine-inspired derivatives against oxidized ldl-induced endothelial injury by activating Nrf2 anti-oxidation pathway. Bioorg Chem 2022; 120: 105606
    CrossrefPubMedGoogle Scholar
  • 36 Zhaolin Z, Jiaojiao C, Peng W. et al. OxLDL induces vascular endothelial cell pyroptosis through miR-125a-5p/TET2 pathway. J Cell Physiol 2019; 234 (05) 7475-7491
    CrossrefPubMedGoogle Scholar
  • 37 Yang H, Mohamed AS, Zhou SH. Oxidized low density lipoprotein, stem cells, and atherosclerosis. Lipids Health Dis 2012; 11: 85
    CrossrefPubMedGoogle Scholar
  • 38 Claesson-Welsh L, Welsh M. VEGFA and tumour angiogenesis. J Intern Med 2013; 273 (02) 114-127
    CrossrefPubMedGoogle Scholar
  • 39 Li Y, Ge J, Ma K, Kong J. Epigallocatechin-3-gallate exerts protective effect on epithelial function via PI3K/AKT signaling in thrombosis. Microvasc Res 2022; 144: 104408
    CrossrefPubMedGoogle Scholar
  • 40 Li Y, Ge JP, Ma K, Yin YY, He J, Gu JP. The combination of EGCG with warfarin reduces deep vein thrombosis in rabbits through modulating HIF-1α and VEGF via the PI3K/AKT and ERK1/2 signaling pathways. Chin J Nat Med 2022; 20 (09) 679-690
    PubMedGoogle Scholar
  • 41 Meng Y, Yin Q, Ma Q. et al. FXII regulates the formation of deep vein thrombosis via the PI3K/AKT signaling pathway in mice. Int J Mol Med 2021; 47 (05) 87
    CrossrefPubMedGoogle Scholar